Autophagy inhibition may prove to be a valuable tool for overcoming TKI resistance when treating chronic myeloid leukemia.
Oncologists are adding new agents to their arsenal against MCL.
This fact sheet offers tips to help patients with chronic myelogenous leukemia overcome challenges to adhering to treatment regimens.
Patients with CML may need help sorting through treatment options, managing side effects, and finding financial aid. This fact sheet is designed to offer support in these areas.
This fact sheet educates patients about what causes chronic myelogenous leukemia (CML) and how it can be treated.
This fact sheet explains myelofibrosis, treatment options, and quality of life issues to help patients and their loved ones cope with a diagnosis.
These tips can help patients with multiple myeloma learn more about how to cope with the disease.
"Serial killer" T cells produce sustained responses in patients with leukemia.
For patients with resistance to or intolerance of imatinib, bosutinib is a promising alternative therapy option for CML.
A phase 1b/2, open-label study finds a low rate of severe adverse events as well as promising efficacy data.
Great strides have been made in cancer research this year, including targeted therapies that may soon be used as a standard of care.
Although ponatinib was given accelerated approval by the FDA, it was withdrawn based on evidence of serious thrombotic adverse events.
A 23-year-old patient with Hodgkin lymphoma was seen as an inpatient consultation for a pruritic rash that had been present ...
By Justin M. Watts, MD; Peter Maslak, MD; Martin S. Tallman, MD
A 47-year-old woman presented for evaluation of pancytopenia. She ...
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|